Accounts Timetable and Asset Disposal Update

/**/

RNS Number : 5657M Pacsco Ltd 23 December 2025  

  23 December 2025 PACSCo Limited ('PACSCo' or the 'Company')   2025 Annual and 2026 Interim Accounts Timetable And Update on Mozambique Asset Disposal     2025 Annual and 2026 Interim Accounts Timetable Further to the Company's announcement on 28 November 2025, PACSCo Limited provides the following update on its 2025 Annual Accounts and its 2026 unaudited Interim Accounts.  As shareholders are aware, due to the delay in publishing the 2025 Annual Accounts, dealings in the Company's Ordinary Shares have been suspended from trading on AIM. It is currently anticipated that the 2025 Annual Accounts and the 2026 unaudited Interim Accounts, for the periods ending 31 March 2025 and 30 September 2025, respectively, will both be finalised and published in in the course of January 2026, which will enable an application to be made for the ongoing trading suspension to be lifted. Update on Mozambique Asset Disposal The Company is pleased to announce that it has received the approval for the disposal of the Mozambique Agricultural Businesses from the Mozambique Competition Regulatory Authority. The Company is working with the Bank of Mozambique to obtain the necessary regulatory approval.         ** ENDS **   The information contained within this announcement is considered to be inside information prior to its release, as defined in Article 7 of the Market Abuse Regulation No. 596/2014, and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.   For further information please visit www.pacsco.co.uk or contact:

PACSCo Limited

Caroline Havers caroline@agriterra-ltd.com

Strand Hanson Limited Nominated & Financial Adviser  

Ritchie Balmer / James Spinney +44 (0) 207 409 3494

AlbR Capital Limited Broker

Duncan Vasey / Heena Karani +44 (0) 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  MSCFFFEFFRLFFIE